The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Open accessAbstract
EZ Inhibition: Missense mutations in the core constituents of the genome packaging material, chromatin, have been implicated in several of human cancers. Nucleosomes are made up of histones, and a mutation of lysine 27 (K27) to methionine in the N-terminal tail of histone variants H3.3 and H3.1 has been identified in various pediatric gliomas. Lewis et al. (p. 857 , published online 28 March; see the Perspective by Morgan and Shilatifard ) show that the polycomb enzyme complex, which can epigenetically modify K27 by addition of a methyl group—and which is often a silencing signal—is itself potently inhibited by replacement of the H3.3/3.1 K27 by methionine. The inhibition of the EZH2 subunit causes an overall reduction of K27 methylation. Methionine mutants of other methylated lysine residues in histone H3 cause similar reductions in methylation levels of the cognate lysine, altering the epigenetic profiles of such cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, tumor cells with the K27M mutation exhibit low levels of H3K27me3 and aberrant gene silencing (4,(7)(8)(9).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“act in a dominant manner to deplete H3K27 methylation by inhibiting PRC2 methyltransferase activity [5, 6]”
From Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling (2014) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Additional histone H3 lysine-to-methionine mutants possess dominant gain-of-function activities [6]”
From Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling (2014) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“We and others previously showed that K-to-M oncohistones transform the histone H3 proteins into potent inhibitors of specific lysine methyltransferase enzymes (4-7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies showed that the K27M mutation found in pediatric glioma is sufficient to transform histone H3 into a potent inhibitor of enzymatic activity of PRC2 (4, 5, 7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“we previously showed that H3K9M peptides are capable of inhibiting activity of SUV39H1 and G9a, two H3K9-directed methyltransferases, in vitro (7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Previously, we found that only long, unbranched hydrophobic side chains containing methionine (M) and isoleucine (I) at lysine 27 (K27M and K27I) were capable of inhibiting PRC2 in vitro and decreasing H3K27me3 when expressed ectopically in cultured cells (7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
In the citing paper
“Despite reports supporting a higher affinity of PRC2 for H3K27M as compared with wild-type H3 108-110 , H3K27M was often inversely correlated with PRC2 occupancy, challenging the idea that H3K27M sequesters PRC2 on chromatin 111,112 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [112]
In the citing paper
“Expression of the histone mutant is accompanied by a reduction in the levels of Polycomb Repressive Complex 2 (PRC2) mediated H3K27 trimethylation (H3K27me3) and this is purported to be a driving event of DIPG oncogenesis4,5.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Interestingly upon loss of H3K27me3 these nucleosomes acquire H3K27ac resulting in the formation of H3K27M-K27ac heterotypic nucleosomes4 (Figure 1D and Supplementary Fig. 5B–C).”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“As shown by our group and others, H3K27M expression is associated with increased levels of H3K27ac4,5 (Fig. 1D).”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Although still functionally active, PRC2 catalytic property toward H3K27M containing nucleosomes is strongly inhibited4.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Collectively, these results strongly indicate that H3K27M in DIPG cells does not appear to recruit or sequester EZH2 (or in general PRC2), as suggested by other studies4,6,7.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Attempts to model H3.3K27M-driven HGG formation in vivo via genetic recombination in neural progenitor/stem cells (NPCs) in the postnatal brain failed to demonstrate tumor-driving activity”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Lewis et al., 2013
In the citing paper
“H3.3K27M has been shown to have gain-of-function activity inhibiting the Polycomb Repressive Complex 2 (PRC2) (Bender et al., 2013; Lewis et al., 2013), which in turn leads to a global reduction in H3K27me3 levels in primary tumors and tumor-derived primary cells.”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Lewis et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,476
Self-citationRole of the polycomb protein EED in the propagation of repressive histone marks
Margueron, R., Justin, N., Ohno, K., Sharpe, M. L., Son, J., Drury, W. J., Voigt, P., Martin, S. R., Taylor, W. R., Marco, V. D., et al. (2009) · Nature · doi:10.1038/nature08398 · Cited by 1,281
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 880
Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 719
Yap, D., Chu, J., Berg, T., Schapira, M., Cheng, S., Moradian, A., Morin, R. D., Mungall, A. J. J., Meissner, B., Boyle, M., et al. (2010) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 633
A Novel Mammalian Flavin-dependent Histone Demethylase
Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C., & Mattevi, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003087 · Cited by 274
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–999 of 999
Kori, Y., Lund, P. J., Trovato, M., Sidoli, S., Yuan, Z., Noh, K., & Garcia, B. A. (2022) · Molecular Omics · doi:10.1039/d1mo00352f · Cited by 7
Self-citationKrug, B., Hu, B., Chen, H., Negrón-Lomas, C., Chen, X., Mouatani, A. E., Gretarsson, K. H., Ptack, A., Deshmukh, S., Kabir, N., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02586-y · Cited by 9
Self-citationTetens, A. R., Martin, A. M., Arnold, A., Novak, O., Idrizi, A., Tryggvadóttir, R., Craig-Schwartz, J., Liapodimitri, A., Lunsford, K., Barbato, M. I., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae023 · Cited by 7
The many faces of H3.3 in regulating chromatin in embryonic stem cells and beyond
Cohen, L. R. Z., & Meshorer, E. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.03.003 · Cited by 8
Histone exchange: sculpting the epigenome
Terweij, M., & van Leeuwen, F. (2013) · Frontiers in Life Science · doi:10.1080/21553769.2013.838193 · Cited by 8
Jiao, L., & Liu, X. (2016) · Science · doi:10.1126/science.aaj2335 · Cited by 7
Job Opening for Nucleosome Mechanic: Flexibility Required
Pitman, M., Melters, D. P., & Dalal, Y. (2020) · Cells · doi:10.3390/cells9030580 · Cited by 6
Oliveira, V. F., de Sousa, G. R., dos Santos, A. C., Saggioro, F. P., Machado, H. R., de Oliveira, R. S., Tone, L. G., & Valera, E. T. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04852-8 · Cited by 7
Brain stem gliomas and current landscape
Wummer, B. M., Woodworth, D., & Flores, C. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03655-w · Cited by 7
Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3_8 · Cited by 7
Modulation of H3.3 chromatin assembly by PML: A way to regulate epigenetic inheritance
Delbarre, E., & Janicki, S. M. (2021) · BioEssays · doi:10.1002/bies.202100038 · Cited by 7
Practical Molecular Pathologic Diagnosis of Infiltrating Gliomas
Pekmezci, M., & Perry, A. (2014) · Surgical pathology clinics · doi:10.1016/j.path.2014.10.004 · Cited by 7
Baas, R., Lelieveld, D., van Teeffelen, H. A. A. M., Lijnzaad, P., Castelijns, B., van Schaik, F. M. A., Vermeulen, M., Egan, D. A., Timmers, H. T. M., & de Graaf, P. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113515024 · Cited by 7
Proteomic approaches for cancer epigenetics research
Marchione, D. M., Garcia, B. A., & Wojcik, J. B. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1550363 · Cited by 7
Self-citationCDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?
Becher, O. J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.020 · Cited by 7
Self-citationChemical and biophysical methods to explore dynamic mechanisms of chromatin silencing
Boichenko, I., & Fierz, B. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.01.022 · Cited by 7
Replication-coupled inheritance of chromatin states
Song, A., Wang, Y., Liu, C., Yu, J., Zhang, Z., Lan, L., Lin, H., Zhao, J., & Li, G. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100195 · Cited by 6
Seblani, M. D., Ζαννίκου, Μ., Duffy, J. T., Joshi, T., Levine, R., Thakur, A., Vallcorba, M. P., Horbinski, C., Miska, J. M., Hambardzumyan, D., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01991-4 · Cited by 6
Self-citationHolliday, H., Khan, A., Ehteda, A., Nguyen, H., Ross, S. E., Jayatilleke, N., Gopalakrishnan, A., Wang, E., Colino‐Sanguino, Y., Kavanagh, D., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adr1557 · Cited by 6
Wadhwani, N. R., Nayak, S., Wang, Y., Hashizume, R., Jie, C., Mania-Farnell, B. L., James, C. D., Xi, G., & Tomita, T. (2023) · Cancers · doi:10.3390/cancers15133429 · Cited by 6
CASTILHO, R. M., Castilho, L. S., Palomares, B. H., & SQUARIZE, C. H. (2024) · Genes · doi:10.3390/genes15060710 · Cited by 6
Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders
Weekley, B. H., Ahmed, N. I., & Maze, I. S. (2025) · iScience · doi:10.1016/j.isci.2025.112092 · Cited by 7
H3.1K27M-induced misregulation of the TONSOKU-H3.1 pathway causes genomic instability
Yuan, W., Huang, Y.-C., LeBlanc, C., Poulet, A., Vitorino, F. N. D. L., Valsakumar, D., Dean, R., Garcia, B. A., van Wolfswinkel, J. C., Voigt, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58892-2 · Cited by 7
Self-citationUnravelling the biology of chromatin in health and cancer using proteomic approaches
Kempf, C. G., Dayebgadoh, G., Liu, X., & Washburn, M. P. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1374860 · Cited by 6
Morris, M., Driscoll, M., Henson, J. W., Cobbs, C., Jiang, L., Gocke, C. D., Chen, L., & Rodríguez, F. J. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa101 · Cited by 6
(2020) · Journal of Experimental Neurology · doi:10.33696/neurol.1.025 · Cited by 6
Gong, Y., Xu, F., Deng, L., & Peng, L. (2022) · BioMed Research International · doi:10.1155/2022/2244228 · Cited by 6
RetractedChromatin mutations in pediatric high grade gliomas
Voon, H. P. J., & Wong, L. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1104129 · Cited by 6
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes
Zhang, L., & Bordey, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188951 · Cited by 7
Nucleosomal asymmetry: a novel mechanism to regulate nucleosome function
Valsakumar, D., & Voigt, P. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230877 · Cited by 6
Miró-Pina, C., Charmant, O., Giovannetti, M., de Vanssay, A., Frapporti, A., Humbert, A., Lhuillier‐Akakpo, M., Chevreux, G., Arnaiz, O., & Duharcourt, S. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1048 · Cited by 6
Regulatory variation: an emerging vantage point for cancer biology
Li, L., Lorzadeh, A., & Hirst, M. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1250 · Cited by 5
Karantanos, T., & Boussiotis, V. A. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.11 · Cited by 6
Regulation of BS69 Expression in Cancers
Chen, Y., Tsai, Y., & Tseng, S. (2019) · Anticancer Research · doi:10.21873/anticanres.13477 · Cited by 6
Understanding the epigenetic landscape and cellular architecture of childhood brain tumors
Cruzeiro, G. A. V., Rota, C., Hack, O. A., Segal, R. A., & Filbin, M. G. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104940 · Cited by 7
Oncohistones: corruption at the core
Jain, K., & Strahl, B. D. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00764-z · Cited by 6
Tracking the Dynamic Histone Methylation of H3K27 in Live Cancer Cells
Gong, Y., Wei, C., Cheng, L., Ma, F., Lu, S., Qin, P., Liu, L., & Wang, Y. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01670 · Cited by 6
Dong, F., Gan, H., Wang, H., Zhou, H., & Zhang, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1281483 · Cited by 7
Untangling the role of mutant histone H3 in diffuse intrinsic pontine glioma
Creasy, C. L. (2017) · Nature Medicine · doi:10.1038/nm.4320 · Cited by 6
Control of Intra-Thymic αβ T Cell Selection and Maturation by H3K27 Methylation and Demethylation
Bosselut, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00688 · Cited by 6
[Lower limb monoplegia and dissociated hypoesthesia after peridural anesthesia].
Fernández, M. F., Dachy, B., & Demeurisse, G. (1999) · PubMed · Cited by 6
Zhang, Y., Justin, N., Wilson, J. R., & Gamblin, S. J. (2016) · Science · doi:10.1126/science.aaf6236 · Cited by 7
G34R cancer mutation alters the conformational ensemble and dynamics of the histone H3.3 tails
Fuchs, H. A., Peng, Y., Ayyapan, S., Rosas, R., Zhang, H., Panchenko, A. R., & Musselman, C. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1381 · Cited by 5
Sun, Z., Zhu, Y., Feng, X., Liu, X., Zhou, K., Wang, Q., Zhang, H., & Shi, H. (2022) · Cancers · doi:10.3390/cancers14194836 · Cited by 5
Day, C. A., Grigore, F., Hakkim, F. L., Paul, S., Langfald, A., Weberg, M., Fadness, S., Schwab, P. M., Sepaniac, L. A., Stumpff, J. K., et al. (2024) · Current Biology · doi:10.1016/j.cub.2024.11.035 · Cited by 5
Ohkuni, K., Au, W.-C., Kazi, A. Z., Balachandra, V. K., & Basrai, M. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf083 · Cited by 5
Regulation of Genome Architecture in Huntington’s Disease
Portillo‐Ledesma, S., Hang, M., & Tamar Schlick, A. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00029 · Cited by 5
Sangree, A. K., Angireddy, R., Bhattarai, J. P., Wang, Y., Bryant, L. M., Waxman, E. A., Layo-Carris, D. E., Durham, E. L., Katsura, K. A., Lubin, E. E., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07175-x · Cited by 5
The changing chromatome as a driver of disease: A panoramic view from different methodologies
Espejo, I., Croce, L. D., & Aranda, S. (2020) · BioEssays · doi:10.1002/bies.202000203 · Cited by 5
Genetic Impairments of PRC2 Activity in Oncology: Problems and Prospects
Chetverina, D., Ломаев, Д. В., Georgiev, P. G., & Erokhin, M. (2021) · Russian Journal of Genetics · doi:10.1134/s1022795421030042 · Cited by 5
Chiarelli, P. A., Chu, J. K., & Krieger, M. D. (2019) · Springer eBooks · doi:10.1007/978-3-319-31512-6_89-1 · Cited by 5
Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies
Foss, A., & Pathania, M. (2023) · Developmental Neuroscience · doi:10.1159/000531040 · Cited by 8
Rechberger, J. S., Bouchal, S. M., Power, E. A., Nonnenbroich, L. F., Nesvick, C. L., & Daniels, D. J. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2277232 · Cited by 5
Bentayebi, K., Suwan, K., Ibrahimi, A., Louati, S., Ouadghiri, M., Aanniz, T., Amzazi, S., Belyamani, L., Hajitou, A., & Eljaoudi, R. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100113 · Cited by 5
Polycomb and Trithorax factors in transcriptional and epigenetic regulation
Lau, P. N. I., & So, C. W. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-799958-6.00004-4 · Cited by 5
Khella, M. S., Bröhm, A., Weirich, S., & Jeltsch, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228832 · Cited by 5
Patrimonio cultural y patrimonio natural: ¿Una pareja imposible?
Fernández, M. Á. Q. (1995) · Extremadura arqueológica · Cited by 5
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms
DiNapoli, S. E., Martinez-McFaline, R., Shen, H., Doane, A. S., Perez, A. R., Verma, A., Simon, A., Nelson, I. S., Balgobin, C. A., Bourque, C., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.814216 · Cited by 5
The histone methyltransferase SETD2 negatively regulates cell size
Molenaar, T. M., Malik, M., Silva, J., Liu, N. Q., Haarhuis, J. H. I., Ambrosi, C., Kwesi‐Maliepaard, E. M., van Welsem, T., Baubec, T., Faller, W. J., et al. (2022) · Journal of Cell Science · doi:10.1242/jcs.259856 · Cited by 5
Neue Aspekte zum Riesenzelltumor des Knochens
Lüke, J., Hasenfratz, M., Mӧller, P., & Barth, T. F. E. (2017) · Der Pathologe · doi:10.1007/s00292-017-0391-9 · Cited by 5
Fostering open collaboration in drug development for paediatric brain tumours
Wong, J. F., Brown, E., Williams, E., & Bullock, A. N. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190315 · Cited by 5
Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors
Nemtsova, M. V., Mikhaylenko, D. S., Kuznetsova, E., Bykov, I. I., & Zamyatnin, A. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920070020 · Cited by 5
Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3
Lim, J., Park, J. H., Baude, A., Fellenberg, J., Zustin, J., Haller, F., Krücken, I., Kang, H. G., Park, Y. J., Plass, C., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.283 · Cited by 5
Spatially controlled construction of assembloids using bioprintingPreprint
Roth, J. G., Brunel, L. G., Huang, M. S., Cai, B., Liu, Y., Sinha, S., Yang, F., Pașca, S. P., Shin, S., & Heilshorn, S. C. (2023) · Research Square · doi:10.21203/rs.3.rs-2389192/v1 · Cited by 5
Aberrant histone modifications in pediatric brain tumors
Hamanishi, E. T., Dang, D., & Venneti, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1587157 · Cited by 4
Cassim, A., Colino‐Sanguino, Y., Fox, S. L., de la Fuente, L. R., Hartley, H. E., & Valdés‐Mora, F. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10284-0 · Cited by 8
Pfaff, E., Schramm, K., Blattner-Johnson, M., Jones, B. C., Stark, S., Balasubramanian, G. P., Previti, C., Autry, R. J., Fiesel, P., Sahm, F., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02945-9 · Cited by 4
Hrycaj, S., Chan, M. P., Venneti, S., Harms, K. L., & Harms, P. W. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100945 · Cited by 4
Debily, M.-A., Teuff, G. L., Kergrohen, T., Varlet, P., Castel, D., Leblond, P., Hargrave, D. R., Nysom, K., Blomgren, K., McCowage, G. B., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04354-1 · Cited by 4
The mechanistic GEMMs of oncogenic histones
Lindroth, A. M., Park, Y. J., Matía, V., & Squatrito, M. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa143 · Cited by 4
Nucleosome proteostasis and histone turnover
Arrieta, A., & Vondriska, T. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.990006 · Cited by 4
Roach, J. T., Riviere-Cazaux, C., Wells, B., Boop, F. A., & Daniels, D. J. (2024) · Child s Nervous System · doi:10.1007/s00381-024-06395-8 · Cited by 4
Algranati, D., Oren, R., Dassa, B., Fellus-Alyagor, L., Plotnikov, A. N., Barr, H. M., Harmelin, A., London, N., Ron, G., Furth, N., et al. (2024) · eLife · doi:10.7554/elife.96257 · Cited by 9
Yamamoto, Y., Takahashi, R., Kinehara, M., Yano, K., Kuramoto, T., Shimamoto, A., & Tahara, H. (2024) · Genes · doi:10.3390/genes15050543 · Cited by 4
Kong, Y., Wang, F., Jing, R., Zhao, Q., Lv, X., Zhao, Y., Yuan, Y., Xia, X., Sun, Y., Tong, Y., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2227 · Cited by 4
Bhattarai, S., Hakkim, F. L., Day, C. A., Grigore, F., Langfald, A., Entin, I., Hinchcliffe, E. H., & Robinson, J. P. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00585-7 · Cited by 4
Arfè, S., Karagyozova, T., Forest, A., Bingham, D., Hmidan, H., Mazaud, D., Garnier, M., Baccon, P. L., Meshorer, E., Quivy, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60430-z · Cited by 4
Histone Modifications and Histone Variants in Pluripotency and Differentiation
Bannister, A. J., Falcão, A. M., & Castelo‐Branco, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803395-1.00002-2 · Cited by 4
CAR T cells for childhood diffuse midline gliomas
Ramaswamy, V., & Taylor, M. D. (2018) · Nature Medicine · doi:10.1038/s41591-018-0031-9 · Cited by 4
Wang, J., & Lu, Q. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105040 · Cited by 5
Raby, L., Völkel, P., Hasanpour, S., Cicero, J., Toillon, R., Adriaenssens, É., SEUNINGEN, I. V., Bourhis, X. L., & Angrand, P. (2021) · Cells · doi:10.3390/cells10113142 · Cited by 5
The cancer epigenome: Non‐cell autonomous player in tumor immunity
Kato, S., Maeda, Y., Sugiyama, D., Watanabe, K., Nishikawa, H., & Hinohara, K. (2022) · Cancer Science · doi:10.1111/cas.15681 · Cited by 3
Abdallah, A. S., Cardona, H. J., Gadd, S., Brat, D. J., Powla, P. P., Alruwalli, W. S., Shen, C., Picketts, D. J., Li, X., & Becher, O. J. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad003 · Cited by 4
Self-citationDiffuse intrinsic pontine glioma: Insights into oncogenesis and opportunities for targeted therapy
Groves, A. P., Bandopadhayay, P., & Cooney, T. M. (2023) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2023.02.003 · Cited by 4
Mac, M., DeVico, B. M., Raspanti, S. M., & Moody, C. A. (2023) · Journal of Virology · doi:10.1128/jvi.00201-23 · Cited by 4
(B)On(e)-cohistones and the epigenetic alterations at the root of bone cancer
Salomoni, P., Flanagan, A. M., & Cottone, L. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01227-9 · Cited by 4
Alterations of histone modifications in cancer
Saber-Ayad, M. M., Ramadan, W. S. H., & El‐Awady, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00018-x · Cited by 5
Kinetic Resolution of Epimeric Proteins Enables Stereoselective Chemical Mutagenesis
Ablat, G., Lawton, N., Alam, R., Haynes, B. A., Hossain, S., Hicks, T., Evans, S. L., Jarvis, J. A., Nott, T. J., Isaacson, R. L., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c07103 · Cited by 3
Self-citationHistone H3 mutations and their impact on genome stability maintenance
Caeiro, L. D., Verdún, R. E., & Morey, L. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240177 · Cited by 4
Invited Review: The role and contribution of transcriptional enhancers in brain cancer
Arabzade, A., Stuckert, A. J., Bertrand, K. C., & Mack, S. C. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12612 · Cited by 4
An Update on Pediatric Gliomas
Ahrendsen, J. T., & Alexandrescu, S. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.02.005 · Cited by 4
Genetically altered cancer epigenome
Tang, M., Luo, H., & Lu, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-799958-6.00012-3 · Cited by 4
“Modifying” My Career toward Chromatin Biology
Allis, C. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.x115.663229 · Cited by 4
Self-citationGulzar, N., Dingerdissen, H., Yan, C., & Mazumder, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6783-4_8 · Cited by 4
Diffuse Midline Glioma – Diffuse Intrinsic Pontine Glioma
Noureldine, M. H. A., Shimony, N., & Jallo, G. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-38774-7_8 · Cited by 4
Global chromatin architecture defines functional cancer hierarchies
Gallo, M., & Dirks, P. B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191248 · Cited by 4
Histone Variants: Structure, Function, and Implication in Diseases
Alvarez, F., & Loyola, A. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch7 · Cited by 3
Cui, E., Maddock, R. J., Buonocore, M. H., Öztürk, M., & Yoon, J. H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/381699 · Cited by 4
Dynamic association of H3K36me3 with pericentromeric heterochromatin regulates its replication time
Pradhan, S. K., Zhang, H., Kolobynina, K. G., Rapp, A. W., Arroyo, M. D. C. G., & Cardoso, M. C. (2025) · EMBO Reports · doi:10.1038/s44319-025-00575-6 · Cited by 3
Metadata
- Authors
- Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D.
- Affiliations
- Rockefeller University (US)
- Princeton University (US)
- Duke University (US)
- University of Pennsylvania (US)
- Corresponding author
- Allis, C. David
- ORCID
- Venue
- Science
- Published
- 2013-05-17
- Volume
- 340
- Issue
- 6134
- Pages
- 857-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3951439
- OpenAlex
- W1995105508
- Cited by
- 1,345
- References
- 14
- Citations by year
- 2026: 73 · 2025: 82 · 2024: 103 · 2023: 106 · 2022: 103 · 2021: 118 · 2020: 146 · 2019: 112 · 2018: 84 · 2017: 102 · 2016: 90 · 2015: 95 · 2014: 87 · 2013: 40
- FWCI
- 51.21
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institutes of Health (DP2OD007447)
- National Institute of Mental Health (P50MH096890)
- National Institute of General Medical Sciences (GM040922, R01GM107047, R01GM040922)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pediatric glioblastoma, diffuse intrinsic pontine glioma, H3K27M mutation, histone H3.3, H3K27me3, polycomb repressive complex 2, EZH2, histone methylation, gain-of-function mutations, epigenetic regulation
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, Animals, Brain Neoplasms, Child, Glioblastoma, Histones, Humans, Lysine, Methionine, Methylation, Transgenes, Amino Acid Substitution, Mutation, Missense, Epigenesis, Genetic, Mice, HEK293 Cells, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
